At What Age Should Children Be Tested for Inherited ADPKD?
At a Glance
There is no single required age to test an asymptomatic child at risk for inherited ADPKD. Families may choose childhood testing or delay it, but regular blood pressure and urine monitoring remains important, guided by a pediatric nephrologist and genetic counselor.
In this answer
4 sections
There is no universally required age to test an asymptomatic child for autosomal dominant polycystic kidney disease (ADPKD). Because each child of an affected parent has a 50% chance of inheriting the condition [1], it is entirely normal for parents to feel anxious and want definitive answers immediately. However, international pediatric guidelines consider two options equally valid for an asymptomatic child who is “at risk” (meaning they have an affected parent but their own status is unknown): you can pursue immediate diagnostic testing, or you can delay testing while closely monitoring the child for treatable childhood symptoms [2][3].
The decision to test a child is highly individualized and should be made through shared decision-making with a medical team, taking into account the child’s maturity and the family’s values [4].
The Decision: Testing vs. Monitoring
In medical genetics, the general default approach for adult-onset conditions is to postpone predictive testing (testing someone before they have symptoms) until the child is mature enough to make their own autonomous decision [5][6]. However, ADPKD is a unique case because it can cause medically actionable issues during childhood, making early testing a reasonable choice for some families [7][2].
Reasons families may choose to delay testing:
- Preserving Autonomy: Delaying the test protects the child’s “right to an open future,” allowing the future adult to decide if they want to live with the knowledge of a genetic diagnosis [8][9].
- Avoiding Premature Labeling: A childhood diagnosis can sometimes cause psychological distress or change how a child is treated by their family [10][11].
- Protecting Future Opportunities: Depending on your specific country and local laws, a documented genetic diagnosis on a medical record could potentially complicate a young adult’s future ability to secure certain types of life insurance or employment [10]. Protections vary widely by jurisdiction, so it is important to consult a genetic counselor about local laws.
Reasons families may choose to test now:
- Guiding Care: A confirmed diagnosis can clarify the need for ongoing medical monitoring [7].
- Resolving Uncertainty: For some families, knowing the diagnosis is less anxiety-inducing than living with the unknown [11].
As children mature, their views on testing should be considered, and they should be included in the conversation in an age-appropriate way [12].
Why Monitoring is Essential (Even Without a Diagnosis)
If you decide to delay predictive testing, your child still requires active medical care. Children with a family history of ADPKD should undergo regular health screenings, even if their official disease status is unknown [2].
The primary clinical reason to monitor at-risk children is to catch treatable symptoms early. While kidney function typically remains normal during childhood, research shows that up to 35% of children with confirmed ADPKD develop high blood pressure (hypertension) [13]. Guidelines recommend that all at-risk children be regularly checked for:
- High Blood Pressure: Current consensus guidelines often recommend starting regular blood pressure checks around age 5, typically repeated every 1 to 2 years, though local guidelines may vary [2]. While clinic visits are standard, specialists often utilize a 24-hour ambulatory blood pressure monitor (a wearable device that takes readings throughout the day and night) when feasible, as it can detect hidden high blood pressure that a clinic check might miss [2][13].
- Protein in the Urine: Urine tests should be performed to check for albuminuria (protein in the urine), which can be an early sign of kidney stress [2][14].
If a child develops persistent high blood pressure or albuminuria, it warrants thorough medical evaluation and, when appropriate, treatment (such as blood pressure medication) that may reduce long-term risk to the kidneys [2].
Note: If your child experiences severe or persistent pain, fever with urinary symptoms, visible blood in the urine, or severe headaches, seek prompt medical attention regardless of whether they have been tested for ADPKD [15].
Diagnostic Screening Options
If your family and medical team decide that diagnostic testing is the right path, there are two primary methods:
- Kidney Ultrasound: This is the standard, preferred imaging test to screen at-risk children [2][16]. It is non-invasive and accessible. However, because ADPKD cysts grow slowly over time, a negative ultrasound in a young child does not definitively rule out the disease; the cysts may simply be too small to detect yet [2][17].
- Genetic Testing: DNA testing can provide a definitive answer. It is most informative when the affected parent has already been tested to identify their specific pathogenic variant (the exact genetic mutation causing their disease). The child can then be tested specifically for that familial variant [18][19]. Broad genetic panels are also used when the family history is unclear, when a child shows very early or severe symptoms, or when the disease behaves atypically [2][20].
Making the Decision as a Family
Testing a child for ADPKD is a complex decision that involves weighing psychological, ethical, and medical factors [4]. There is no single “right” choice for every family.
Working with a genetic counselor and a pediatric nephrologist is highly recommended [10][2]. They can help you navigate your concerns, explain the exact monitoring schedule appropriate for your child, and support a shared decision-making process that prioritizes your child’s physical and emotional well-being [4].
Common questions in this guide
Is there one recommended age for testing an asymptomatic child for ADPKD?
What is the chance my child will inherit ADPKD if I have it?
What happens if we wait to test our child for inherited ADPKD?
Can a normal kidney ultrasound rule out ADPKD in a young child?
How can genetic testing confirm whether a child inherited ADPKD?
Why might parents choose not to test their child right away?
Who should help a family decide about ADPKD testing in childhood?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific monitoring schedule (e.g., starting age and interval) for blood pressure and urine tests do you recommend for my child based on current guidelines?
- 2.When checking blood pressure, do you recommend starting with standard clinic visits, or is 24-hour ambulatory blood pressure monitoring a feasible option for a child this age?
- 3.What is the process for genetic testing if we choose that route, and should I (the affected parent) be tested first to identify the specific genetic variant?
- 4.At what age or developmental stage do you usually recommend involving my child in the conversation about their genetic risk and testing options?
- 5.How does a formal genetic diagnosis of a minor affect their medical records, and can you direct us to resources about local laws protecting against genetic discrimination for life insurance?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (20)
- 1
Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney Disease.
Murphy EL, Droher ML, DiMaio MS, Dahl NK
American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(6)):866-872 doi:10.1053/j.ajkd.2018.01.048.
PMID: 29606500 - 2
International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people.
Gimpel C, Bergmann C, Bockenhauer D, et al.
Nature reviews. Nephrology 2019; (15(11)):713-726 doi:10.1038/s41581-019-0155-2.
PMID: 31118499 - 3
Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?
De Rechter S, Breysem L, Mekahli D
Frontiers in pediatrics 2017; (5()):272 doi:10.3389/fped.2017.00272.
PMID: 29326910 - 4
Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD).
Dudley J, Winyard P, Marlais M, et al.
BMC nephrology 2019; (20(1)):148 doi:10.1186/s12882-019-1285-2.
PMID: 31039757 - 5
Human Genetics Society of Australasia Position Statement: Predictive and Presymptomatic Genetic Testing in Adults and Children.
Vears DF, McLean A, La Spina C, et al.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2024; (27(2)):120-127 doi:10.1017/thg.2024.9.
PMID: 38509872 - 6
Human Genetics Society of Australasia Position Statement: Predictive and Presymptomatic Genetic Testing in Adults and Children.
Vears DF, Ayres S, Boyle J, et al.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2020; (23(3)):184-189 doi:10.1017/thg.2020.51.
PMID: 32635964 - 7
Uptake of Predictive Genetic Testing and Cardiac Evaluation for Children at Risk for an Inherited Arrhythmia or Cardiomyopathy.
Christian S, Atallah J, Clegg R, et al.
Journal of genetic counseling 2018; (27(1)):124-130 doi:10.1007/s10897-017-0129-0.
PMID: 28699125 - 8
Rethinking the "open future" argument against predictive genetic testing of children.
Garrett JR, Lantos JD, Biesecker LG, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(10)):2190-2198 doi:10.1038/s41436-019-0483-4.
PMID: 30894702 - 9
Discouraging Elective Genetic Testing of Minors: A Norm under Siege in a New Era of Genomic Medicine.
Hercher L
Cold Spring Harbor perspectives in medicine 2020; (10(5)) doi:10.1101/cshperspect.a036657.
PMID: 31548217 - 10
To do or not to do-genetic testing for autosomal dominant polycystic kidney disease in children and adolescents.
Ma BM, Milo Rasouly H, Sabatello M
Kidney international 2025; (108(1)):17-19 doi:10.1016/j.kint.2025.05.001.
PMID: 40543935 - 11
'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.
Logeman C, Cho Y, Sautenet B, et al.
BMJ open 2020; (10(10)):e038005 doi:10.1136/bmjopen-2020-038005.
PMID: 33040007 - 12
To test or not to test: genetic cancer predisposition testing in paediatric patients with cancer.
Mehta S, Kuo DJ
Journal of medical ethics 2020; doi:10.1136/medethics-2020-106656.
PMID: 33303646 - 13
Prevalence of Hypertension in Children with Early-Stage ADPKD.
Massella L, Mekahli D, Paripović D, et al.
Clinical journal of the American Society of Nephrology : CJASN 2018; (13(6)):874-883 doi:10.2215/CJN.11401017.
PMID: 29674338 - 14
The wind of change in the management of autosomal dominant polycystic kidney disease in childhood.
Gimpel C, Bergmann C, Mekahli D
Pediatric nephrology (Berlin, Germany) 2022; (37(3)):473-487 doi:10.1007/s00467-021-04974-4.
PMID: 33677691 - 15
Macroscopic hematuria in children with autosomal dominant polycystic kidney disease - report from four European tertiary centers.
Seeman T, Bláhová K, Fencl F, et al.
European journal of pediatrics 2026; (185(6)).
PMID: 42098312 - 16
Autosomal dominant polycystic kidney disease.
Srivastava A, Patel N
American family physician 2014; (90(5)):303-7.
PMID: 25251090 - 17
Genetic Testing in Cystic Kidney Disease.
Soraru J, Mallett AJ, McCarthy HJ, Mallawaarachchi A
Kidney360 2026; (7(8)):1909-1914 doi:10.34067/KID.0000001127.
PMID: 41481365 - 18
The screening, diagnosis, and management of patients with autosomal dominant polycystic kidney disease: A national consensus statement from Taiwan.
Yen PW, Chen YA, Wang W, et al.
Nephrology (Carlton, Vic.) 2024; (29(5)):245-258 doi:10.1111/nep.14287.
PMID: 38462235 - 19
Matching clinical and genetic diagnoses in autosomal dominant polycystic kidney disease reveals novel phenocopies and potential candidate genes.
Schönauer R, Baatz S, Nemitz-Kliemchen M, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2020; (22(8)):1374-1383 doi:10.1038/s41436-020-0816-3.
PMID: 32398770 - 20
The First Pediatric Case of an IFT140 Heterozygous Deletion Causing Autosomal Dominant Polycystic Kidney Disease: Case Report.
Seeman T, Šuláková T, Bosáková A, et al.
Case reports in nephrology and dialysis 2024; (14(1)):104-109 doi:10.1159/000539176.
PMID: 39015124
This page is for informational purposes only and is not medical advice. Decisions about testing or monitoring a child at risk for inherited ADPKD should be made with a pediatric nephrologist and genetic counselor.
Get notified when new evidence is published on Autosomal dominant polycystic kidney disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.